[Federal Register Volume 64, Number 123 (Monday, June 28, 1999)]
[Notices]
[Page 34681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-16262]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Registration

    By Notice dated March 1, 1999, and published in the Federal 
Register on April 1, 1999, (64 FR 15808), Lilly Del Caribe, Inc., 
Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 
00680, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
dextropropoxyphene (9273), a basic class of controlled substance listed 
in Schedule II.
    The firm plans to manufacture bulk product for distribution to its 
customers.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Lilly Del 
Caribe, Inc. to manufacture dextropropoxyphene is consistent with the 
public interest at this time. DEA has investigated Lilly Del Caribe, 
Inc. on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic class of controlled substance listed above is 
granted.

    Dated: June 15, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-16262 Filed 6-25-99; 8:45 am]
BILLING CODE 4410-09-M